A Diagnosis That Has Moved From Fringe to Mainstream
Small intestinal bacterial overgrowth (SIBO) is a condition in which abnormally high numbers of bacteria colonize the small intestine. The result is bloating, gas, abdominal pain, diarrhea or constipation, and sometimes nutrient deficiencies. SIBO has emerged from the fringes of gastroenterology into accepted diagnostic and therapeutic territory over the past 10–15 years.
The challenge with SIBO is that it has been over-diagnosed by some and under-diagnosed by others. At Zimmer Medical Group, we approach SIBO with appropriate skepticism: real diagnosis requires real testing, real treatment requires addressing causes, and real success requires looking beyond just antibiotics.
What SIBO Actually Is
The small intestine normally contains relatively few bacteria — most of the gut microbiome lives in the colon. When small intestine bacterial counts rise abnormally, fermentation of carbohydrates produces excess gases (hydrogen, methane, hydrogen sulfide), causing many of the symptoms patients experience.
Three main subtypes are recognized based on the dominant gas produced on breath testing:
- Hydrogen-dominant SIBO — often associated with diarrhea-predominant symptoms
- Methane-dominant SIBO (now often called intestinal methanogen overgrowth, or IMO) — typically associated with constipation
- Hydrogen sulfide-dominant — increasingly recognized; associated with diarrhea, sometimes "rotten egg" smelling gas
Recognizing the Symptoms
Common SIBO symptoms include:
- Bloating, often worsening through the day
- Excessive gas
- Abdominal pain or cramping
- Diarrhea, constipation, or alternating
- Belching after meals
- Sense of fullness after small meals
- Sometimes weight loss, nutrient deficiencies (B12, iron, fat-soluble vitamins)
- Nausea
- Brain fog or fatigue
Many of these overlap with IBS. In fact, SIBO and IBS substantially overlap — research suggests a meaningful percentage of IBS patients have SIBO contributing to their symptoms.
Who Is at Risk
Several conditions predispose to SIBO:
- Anatomic abnormalities: prior abdominal surgery, blind loops, diverticula, adhesions
- Motility disorders: scleroderma, diabetes, hypothyroidism, post-viral gastroenteritis
- Reduced stomach acid: long-term PPI use, prior gastric surgery
- Chronic opioid use — slows motility
- Pancreatic insufficiency
- Inflammatory bowel disease
- Older age
A specific subtype — post-infectious IBS/SIBO — develops after acute gastroenteritis (food poisoning), particularly when the offending pathogens were toxin-producing. The toxin damages the migrating motor complex, the "housekeeping wave" that sweeps the small intestine clean between meals.
Diagnosis: Breath Testing Is Standard
The most widely available diagnostic test is the breath test:
- Patient drinks a sugar substrate (lactulose or glucose)
- Breath samples are collected over 90–180 minutes
- Hydrogen and methane levels are measured
- Specific patterns of rise indicate SIBO
Lactulose breath testing has become the more common protocol because lactulose is not absorbed and reaches the entire small intestine. Glucose breath testing is more specific but may miss distal SIBO.
The gold standard is small bowel aspirate culture during endoscopy with bacterial counts >10^3 organisms/mL — but this is invasive and rarely performed outside research.
Test interpretation has evolved. Current consensus criteria from the North American Consensus on hydrogen and methane breath testing offer specific cutoffs and timing requirements that improve diagnostic accuracy.
What SIBO Is Not
SIBO is not:
- A catch-all explanation for any digestive symptom
- A condition that everyone with bloating has
- Permanently cured by a single course of antibiotics
- Reliably diagnosed without testing
Be cautious of practitioners who diagnose SIBO without testing or who treat symptoms presumptively. Be equally cautious of those who treat SIBO without addressing underlying causes — recurrence is the norm in those cases.
Treatment: An Integrated Approach
Antibiotics
The most evidence-supported treatment:
- Rifaximin (Xifaxan) — minimally absorbed, acts locally in the GI tract; standard course is 550 mg three times daily for 14 days. The most evidence-supported antibiotic for hydrogen-dominant SIBO
- Rifaximin plus neomycin — for methane-dominant SIBO
- Metronidazole — alternative for some cases, particularly methane-dominant
- Other antibiotics — used in specific situations
Rifaximin's appeal is that it stays largely in the gut, doesn't disrupt the colonic microbiome dramatically, and is well tolerated. The downside is cost and limited insurance coverage for SIBO specifically.
Herbal Antimicrobials
Some research suggests herbal preparations (containing oregano, berberine, neem, allicin) can be effective. Evidence is more limited than for antibiotics, but they offer an alternative for patients who can't access or tolerate antibiotics.
Diet
Several dietary approaches can be helpful:
- Low-FODMAP diet — reduces fermentable carbohydrates that feed bacteria; useful for symptom management
- Elemental diet — exclusive use of an amino acid-based formula for 2–3 weeks; highly effective but difficult to maintain
- Avoiding personal trigger foods
Diet alone usually does not eradicate SIBO, but combined with antibiotic treatment, it improves symptoms and may help prevent recurrence.
Prokinetics
To reduce recurrence risk, prokinetic agents (medications that improve motility) are often used after antibiotic treatment:
- Low-dose erythromycin or azithromycin
- Prucalopride — a 5-HT4 agonist
- Tegaserod (returned to market for selected use)
- Metoclopramide — short-term use due to neurological side effects with prolonged use
- Naturals: ginger, certain bitters
The goal is restoring the migrating motor complex to its normal sweeping function.
Address Underlying Causes
Long-term success depends on identifying and addressing what allowed SIBO to develop:
- Treat thyroid disease
- Optimize diabetes control
- Reassess long-term PPI use
- Evaluate for structural abnormalities if recurrent
- Manage opioid use
- Treat underlying inflammatory or autoimmune disease
Recurrence Is Common
SIBO recurs in roughly 25–45 percent of patients within 6–12 months. Repeat treatment is often needed. Recurrence rates are higher when underlying causes are not addressed, which is why thorough evaluation matters.
What Patients Should Know
- SIBO is a real condition with real treatment, but proper diagnosis matters
- Single antibiotic courses often help temporarily; long-term success requires addressing underlying causes
- Treatment is a process, not a single intervention
- Significant improvement is realistic for most patients; complete cure is harder for those with permanent contributing conditions
- Be wary of "test for everything" approaches that order extensive testing of questionable validity
When to See Your Doctor
- Persistent bloating, gas, and abdominal discomfort
- Diarrhea or constipation that has not responded to standard treatment
- Symptoms that started after an episode of gastroenteritis
- Diagnosed IBS that has not improved with appropriate treatment
- Long-term PPI use plus new digestive symptoms
- Unexplained nutrient deficiencies
The American College of Gastroenterology clinical guidelines provide additional information on SIBO diagnosis and management.
Bloating, gas, or IBS-like symptoms not responding to typical treatment? Contact Zimmer Medical Group for an evaluation that considers SIBO and the right testing and treatment when indicated.
